Deputy Director Chen Heping Conducts Research on Medical Device Manufacturing Companies in Changzhou

Recently, Chen Heping, Deputy Director of the Provincial Drug Administration, led a team to Changzhou to conduct a special survey on the medical device industry. They visited the production and R&D frontlines of three innovative product companies, coordinating on-site to solve development challenges and accelerate the transformation of industrial innovation achievements.
The research team visited Ruishen'an Medical Device Co., Ltd., Greatchina Biomedical Technology Co.,Ltd., and Sailuo Medical Technology Co., Ltd. to focus on the development progress of innovative products such as implantable neurostimulators, biodegradable materials, and high-end optical equipment for dental diagnosis and treatment. In response to the companies' requests for clinical trial data interoperability and optimization of registration and inspection cycles, he pointed out that "early intervention and full-process tracking" services should be implemented for innovative products within the province to accelerate their market launch.
Next, the Provincial Drug Administration will continue to deepen the "Research + Service" work model, directing resources to the grassroots and concentrating efforts on the front lines, using pragmatic measures to safeguard the high-quality development of the provincial medical device industry.